DGX (Quest) Company Short-Term Debts

DGX (Quest Diagnostics) - company brandmark

Despite its reliance on physical clinics, robotization of Quest Diagnostics' hubs optimizes costs. This enhances its status as a duopoly leader, able to dictate terms to insurers. The short-term debt trend on the GURU.Markets chart allows us to compare liquidity with payments, with 0.51 reaching a new high. Dominance in the testing segment and partnerships guarantee stable market share expansion.

DGX Quest Diagnostics Inc. Company Short-Term Debt (07/04/2022 - 10/29/2026)

Metric breakdowns and analytics for Quest Corp (DGX)

- current quotes and average value forecast:
Price Chart Quest Diagnostics Incorporated|DGX - Broker Consensus Forecast
- business market valuation indicators:
Market Capitalization Quest Diagnostics Incorporated|DGX - Enterprise Value
- business book valuation details:
Net Assets per Single Share Quest Diagnostics|DGX - Company Book Value|Market Cap to Net Assets Ratio questdiagnostics.com|DGX - Company Assets
- debt level and financial liquidity data:
Debt to Equity Quest Diagnostics|DGX - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Capital Quest Diagnostics|DGX - Company Total Debt Obligations|Debt to Book Capitalization Ratio Quest Diagnostics Incorporated|DGX - Long-Term Debt Volume|Company Short-Term Debt Quest Diagnostics|Quick Liquidity Indicator questdiagnostics.com
- earnings and multiples data:
DGX - Net Profit
Fundamental company analysis:DGX - Quest Diagnostics Incorporated
Mass-produced product of Quest Corp

Fundamental asset screening begins with an analysis of liquidity and debt load. This indicator aggregates all liabilities with a maturity of up to one year, reflecting short-term solvency. The trend of current liabilities allows for an assessment of default risk or the availability of resources for expansion. The reduction in borrowings confirms the financial stability of Quest Diagnostics (DGX). This is critical for maintaining the laboratory network and conducting complex genetic research.

Competitors of Quest Diagnostics

A - Company Short-Term Debt|ILMN (Illumina Inc) - Company Short-Term Indebtedness|EXAS: Company Short-Term Debts|Revvity Corp (RVTY) - Company Short-Term Debts|Company Short-Term Debt Bio-Rad Laboratories|Company Short-Term Debt NNNN|Company Current Liabilities SHC (Sotera Health)|QDEL - Short-Term Debt|Company Short-Term Debt OPKO Corp OPK|Short-Term Debt Volume CareDx (CDNA)|Maravai LifeSciences - Company Short-Term Debts|Short-Term Debt Volume fulgentgenetics.com FLGT|Standard BioTools (LAB) - Company Short-Term Debt|CTKB - Short-Term Debt Volume|Company Short-Term Debt OraSure Technologies Inc|XGN - Short-Term Indebtedness|Company Current Liabilities MDXH (MDxHealth SA)|Company Short-Term Debts luciddx.com (LUCD)|Company Short-Term Debts PRE (Prenetics)|Insight Molecular Diagnostics, Inc. (IMDX) - Short-Term Debt|TRIB - Company Short-Term Debt|Short-Term Debt Volume ProPhase Labs Corp PRPH|AIMD (Ainos, Inc.) - Company Current Liabilities|CODX: Amount of Current Liabilities|Company Current Liabilities HSCS|BMRA: Company Short-Term Loans and Borrowings|Company Short-Term Debts CDIO|Virax Biolabs Corp - Company Short-Term Indebtedness|Company Short-Term Debts BJDX (Bluejay Diagnostics)|Short-Term Debt Volume aspirawh.com (AWH)|Accelerate Diagnostics, Inc. - Company Short-Term Debts|CNTG - Company Short-Term Debts|ENZ: Company Short-Term Debts|Short-Term Indebtedness Fresh2 Group FRES|Company Short-Term Debt Genetic Technologies Ltd|Company Short-Term Indebtedness ME (23andme.com)|Company Short-Term Debt Psychemedics Corporation (PMD)